VCM
IART icon

VeriStar Capital Management’s Integra LifeSciences IART Stock Holding History

VeriStar Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-268,000
Closed -$11.7M – 13
2023
Q4 		$11.7M Hold
268,000
– – 7.69% 8
2023
Q3 		$10.2M Buy
+268,000
New +$11.3M 8.72% 6

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VeriStar Capital Management's IART Position: Q1 2024 in Review

VeriStar Capital Management sold out of Integra LifeSciences (IART) in Q1 2024, closing a stake of 268,000 shares — an estimated $11.7M sold.

VeriStar Capital Management first reported a position in IART in Q3 2023 and held it in 2 quarters. The position peaked at $11.7M in Q4 2023. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.

  • VeriStar Capital Management reported no remaining Integra LifeSciences position as of Q1 2024 after selling out during the quarter.
  • VeriStar Capital Management sold 268,000 Integra LifeSciences shares in Q1 2024, an estimated $11.7M.
  • VeriStar Capital Management first reported a position in Integra LifeSciences in Q3 2023 and held it in 2 quarters.
  • VeriStar Capital Management's Integra LifeSciences position peaked at $11.7M in Q4 2023.
  • 281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.

Based on VeriStar Capital Management's 13F filing for Q1 2024, filed 15 May 2024.